November 26, 2008

Takeda Pharmaceutical Company Limited

Notice regarding Acquisition of the Company’s own shares
(Under the provisions of Articles of Incorporation
pursuant to Article 165 (2) of the Corporation Law of Japan)

OSAKA, Japan, November 26, 2008 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced that its Board of Directors resolved today acquisition of its own shares under Article 156 of the Corporation Law of Japan, as applied pursuant to Article 165 (3) of the Corporation Law, as detailed below:

1. Reason for acquisition of its own shares

To improve capital efficiency and further promote return to shareholders

2. Details of acquisition

(1) Class of shares to be acquired:	Shares of common stock
(2) Number of shares to be acquired:	Up to 11 million shares (equivalent to 1.35% of the total issued shares)
(3) Total amount of shares to be acquired:	Up to 50 billion Yen
(4) Schedule of acquisition:	From November 27, 2008 to December 22, 2008

( Reference )

Treasury shares held by Takeda as of November 25, 2008

•Aggregate number of issued shares （excluding treasury stocks）	800,336,267 shares
•Number of treasury stocks	14,816,128 shares

# # #